Syndax Pharmaceuticals Inc. (SNDX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Syndax Pharmaceuticals In...

NASDAQ: SNDX · Real-Time Price · USD
15.68
0.65 (4.32%)
At close: Sep 26, 2025, 3:59 PM
15.55
-0.83%
After-hours: Sep 26, 2025, 07:34 PM EDT

Syndax Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
154.08M 295.39M 74.36M 221.97M
Short-Term Investments
418.8M 282.19M 410.04M 217.97M
Long-Term Investments
119.52M 29.83M 5.47M n/a
Other Long-Term Assets
217K 680K 9.44M n/a
Receivables
11.24M 1.23M 4.06M 429K
Inventory
366K n/a -4.25M 7.65M
Other Current Assets
10.64M 63K 8.79M 7.27M
Total Current Assets
603.06M 580.88M 481.27M 448.4M
Property-Plant & Equipment
2.02M 1.5M 1.06M 1.26M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
121.76M 32M 15.96M 1.26M
Total Assets
724.82M 612.88M 497.24M 449.66M
Account Payables
11.63M 9.96M 4.35M 5.67M
Deferred Revenue
n/a n/a n/a 12.76M
Short-Term Debt
12.12M n/a n/a n/a
Other Current Liabilities
79.33M 35.92M 18.33M 1.89M
Total Current Liabilities
103.55M 58.1M 29.07M 20.68M
Long-Term Debt
331.56M n/a n/a 19.89M
Other Long-Term Liabilities
331.56M n/a n/a n/a
Total Long-Term Liabilities
333.14M 588K 722K 20.61M
Total Liabilities
436.69M 58.68M 29.79M 41.29M
Total Debt
345.74M 1.64M 1.16M 20.97M
Book Value
288.12M 554.2M 467.45M 408.37M
Book Value Per Share
3.37 7.89 7.69 7.84
Common Stock
9K 8K 7K 6K
Retained Earnings
-1.22B -902.4M -693.04M -543.7M
Comprehensive Income
163K 218K -806K 45K
Shareholders Equity
288.12M 554.2M 467.45M 408.37M
Total Investments
538.32M 312.02M 406.92M 217.97M